KRYXANA®
Brand Name: KRYXANA®
Composition: Ribociclib 200mg Film-Coated Tablets
Target: For oral use
Product Description
Medical Info
KRYXANA® is a advanced prescription oncology medication containing 200mg of Ribociclib, formulated as film-coated tablets for oral administration. Classified as a selective CDK4/6 inhibitor, this targeted therapy works by blocking specific proteins that cause cancer cells to divide and multiply rapidly. It is primarily prescribed in combination with hormone therapies to treat hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in women. By slowing the progression of cancer cells, KRYXANA® helps prolong survival rates and manage tumor growth, requiring precise clinical monitoring to ensure maximum efficacy and patient safety throughout the treatment lifecycle.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
